Soon Hin How (How S Hin)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Anti Inflammatory

Small Cell Lung Cancer

Top Venues

Translational lung cancer research

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Mau-Ern Poh, Sivasubramaniam Balakrishnan, Sin Nee Tan, Muhammad Adil Zainal Abidin, Chong Kin Liam, Jiunn Liang Tan, Yong Kek Pang, Arvindran Alaga, Lye Mun Tho, Soon Hin How
Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer. Translational lung cancer research 13 (7) (2024)
Mau-Ern Poh, Sivasubramaniam Balakrishnan, Sin Nee Tan, Muhammad Adil Zainal Abidin, Chong Kin Liam, Jiunn Liang Tan, Yong Kek Pang, Arvindran Alaga, Lye Mun Tho, Soon Hin How
Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer. Translational lung cancer research 13 (7) (2024)
Egbert F Smit, Christophe Dooms, Jo Raskin, Ernest Nadal, Lye M Tho, Xiuning Li, Julien Mazieres, Soon Hin How, Masahiro Morise, Viola W Zhu, Daniel Shao-Weng Tan, Kristina H Holmberg, Barbara Ellers-Lenz, Svenja Adrian, Sabine Brutlach, Karl M Schumacher, Niki Karachaliou, Yi-Long Wu
INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET -amplified NSCLC and first-line osimertinib resistance. Future oncology (London, England) 18 (9) (2021)